Suchergebnisse - (Subject:"*Pneumonia, Viral")

PubPharm (734)

121

CHROLOQUINE PHOSPHATE AGAINST INFECTION BY THE NOVEL CORONAVIRUS : CHROLOQUINE PHOSPHATE AGAINST INFECTION BY THE NOVEL CORONAVIRUS SARS-CoV-2 (COVID-19): THE HOPE OPEN-LABEL, NON-RANDOMIZED CLINICAL TRIAL - HOPE

enthalten in: WHO International Clinical Trials Registry Platform | 2021

122

Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection : Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection. A Multicenter, Interventional, Randomized, Three Arms Study Design

enthalten in: ClinicalTrials.gov | 2021

123

Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19 : Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19: a Single-center, Observational Retrospective-prospective Comparative Study.

enthalten in: ClinicalTrials.gov | 2021

124

Hemodynamic Effect of Prone Position in Non-intubated Patient With COVID 19 : Hemodynamic Effect of Prone Positioning in Non-intubated Patient With COVID 19 Pneumonia: a Monocentric Prospective Cohort Study

enthalten in: ClinicalTrials.gov | 2021

125

COVIDetection-Net : A tailored COVID-19 detection from chest radiography images using deep learning

enthalten in: Optik | 2021

von Elkorany, A. | Elsharkawy, Z.

126

Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial : Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial

enthalten in: ClinicalTrials.gov | 2021

127

Vascular Abnormalities Detected With Chest CT in COVID-19 : Vascular Abnormalities Detected With Chest CT in COVID-19: Spectrum, Association With Other Lesions, and Correlation With Clinical Severity

enthalten in: ClinicalTrials.gov | 2021

128

Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19 : Spironolactone and Dexamethasone in Patients Hospitalized With Moderate-to-severe COVID-19 (SPIDEX-II): a Randomized Clinical Trial

enthalten in: ClinicalTrials.gov | 2021

129

Anakinra treatment to prevent respiratory failure in COVID-19 : suPAR-GUIDED ANAKINRA TREATMENT FOR VALIDATION OF THE RISK AND EARLY MANAGEMENT OF SEVERE RESPIRATORY FAILURE BY COVID-19: THE SAVE-MORE DOUBLE-BLIND, RANDOMIZED, PHASE III CONFIRMATORY TRIAL

enthalten in: WHO International Clinical Trials Registry Platform | 2021

130

Anakinra treatment to prevent respiratory failure in COVID-19 : suPAR-GUIDED ANAKINRA TREATMENT FOR VALIDATION OF THE RISK AND EARLY MANAGEMENT OF SEVERE RESPIRATORY FAILURE BY COVID-19: THE SAVE-MORE DOUBLE-BLIND, RANDOMIZED, PHASE III CONFIRMATORY TRIAL

enthalten in: WHO International Clinical Trials Registry Platform | 2021